Avammune Therapeutics
United States
Overview
Avammune is an R&D-driven biotech firm developing first-in-class and best-in-class next-generation oncology therapeutics, using computational chemistry and a proprietary molecular library targeting DNA/RNA-binding proteins across immune modulation, targeted therapies, and radiotherapeutics.
Key Facts
- Sector
- Biotech / Oncology Drug Discovery
- Business model
- B2B biotech/pharma partnerships
Focus Areas
Biotech / Oncology Drug Discovery
Related on NestLens
Last updated July 11, 2026